Back to results
US 11,883,528 B2Granted
Compositions and methods for treating pulmonary edema or lung inflammation
AssigneeRegents of the University of Minnesota
InventorsDavid H. Ingbar, Timothy P. Rich, Robert J. Schumacher, Jianxun Lei, Maneesh Bhargava
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition for administering directly to the pulmonary tract of a subject includes a salt of triiodothyronine and a pharmaceutically acceptable buffer, adjusted to a pH of 5.5-8.5. The composition can be administered prophylactically or therapeutically to a subject to treat lung inflammation or pulmonary edema.
Claims3
A method for treating congestive heart failure in a subject, the method comprising:
- administering to the pulmonary tract of the subject a composition comprising an amount of triiodothyronine (T3) effective to ameliorate lung inflammation or pulmonary edema, wherein the composition comprises:
- a salt of triiodothyronine in an amount effective to provide a lung-delivered dose of from 100 ng to 2 mg;
- and
- a pharmaceutically acceptable buffer;
- wherein the composition delivered to the lung has a pH from 5.5 to 8.5 and a maximum volume of no more than 0.30 ml per 1.67 g wet lung weight per dose.
2 more elements
Dependencies are inferred from the claim text.